Anticoagulant-associated heavy menstrual bleeding (HMB) is an underrecognized but not
uncommon problem in clinical practice. Premenopausal women should be advised of the …

Behçet's syndrome (BS) is a complex disease with different organ involvement. The vascular
one is the most intriguing, considering the existence of a specific group of patients suffering …

Background Contemporary incidence data for venous thromboembolism (VTE) from racially
diverse populations are limited. The racial distribution of Oklahoma County closely mirrors …

Venous thromboembolism (VTE) remains a critical issue in the management of patients with
multiple myeloma (MM), particularly when immunomodulatory drugs (IMiDs) combined with …

Venous thromboembolism (VTE) is a multifactorial disease, and its risk depends on
exposure to risk factors and predisposing conditions. Based on their strength of association …

Historically, because of the difficulty of using warfarin safely and effectively, many patients
with cardioembolic stroke who should have been anticoagulated were instead given …

Arterial thrombosis and venous thromboembolism (VTE) are traditionally considered two
different entities. However, patients with unprovoked VTE are at higher risk of developing …

Essentials• The risk of bleeding influences the duration of anticoagulation (AC) after venous
thromboembolism.• We assessed the ACCP bleeding risk score in an inception‐cohort of …

Objective Accumulating evidence demonstrates that gender affirming hormone therapy
improves mental health outcomes in transgender persons. Data specific to the risks …

Abstract Background Extracellular vesicles (EVs), in particular those derived from activated
platelets, are associated with a risk of future venous thromboembolism. Objectives To study …